Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan 30mg vs Placebo in Mild to Moderate Essential Hypertension
NCT01672476Phase 3Completed
- Sponsor
- Boryung
- Start
- Apr 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fimasartan in essential hypertension, sponsored by Boryung. Started Apr 2012; status: completed.
02
Drugs
fimasartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01672476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01672476.